HHealth Read More Experimental Drugs Reverse Autism Symptoms20 August 2025 Summary: Researchers have identified hyperactivity in the reticular thalamic nucleus as a driver of autism-like behaviors in mice.…
HHealth Read More New Drug Targets Brain Glial Cells to Reverse PTSD Symptoms2 August 2025 Key Questions Answered Q: Why do PTSD patients struggle to forget traumatic memories?A: The study reveals that excessive…
HHealth Read More Blocking Opioid Receptors May Restore Healthy Dopamine Balance1 June 2025 Summary: New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that…
HHealth Read More SSRIs Restore Brain Function in Alzheimer’s31 May 2025 Summary: A new study suggests that SSRIs, commonly prescribed antidepressants, may reduce biological markers of Alzheimer’s disease. In…
HHealth Read More Brainstem Neurons Hold Key to Semaglutide’s Weight Loss Effects26 May 2025 Summary: Researchers have identified a specific group of brainstem neurons that mediate the appetite-reducing and weight-loss effects of…
HHealth Read More ALS Drug Shows Unprecedented Recovery in Patients With Rare Mutation25 May 2025 Summary: A groundbreaking experimental therapy for a rare, aggressive form of ALS caused by FUS gene mutations has…
HHealth Read More Gabapentin Linked to Longer Survival in Glioblastoma Brain Cancer15 May 2025 Summary: A new study suggests that gabapentin, a widely used anti-seizure medication, may improve survival in patients with…
HHealth Read More HIV Drugs Linked to Lower Alzheimer’s Risk8 May 2025 Summary: New research shows that HIV drugs called NRTIs may significantly reduce the risk of developing Alzheimer’s disease.…
GGenetics Read More GLP1 agonists linked to depression risk in new genetic study18 April 2025 A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely…
HHealth Read More Ozempic Linked to Lower Alzheimer’s Risk17 April 2025 Summary: A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may…